Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY – Get Free Report) shares were up 6.2% during mid-day trading on Thursday . The stock traded as high as $47.00 and last traded at $46.2144. 5,030 shares traded hands during mid-day trading, an increase of 253% from the average session volume of 1,424 shares. The stock had previously closed at $43.5016.
Hikma Pharmaceuticals Price Performance
The stock’s 50-day simple moving average is $41.32 and its 200 day simple moving average is $39.32.
Hikma Pharmaceuticals Company Profile
Hikma Pharmaceuticals is a multinational pharmaceutical company founded in Amman, Jordan, in 1978. Headquartered in London, the company develops, manufactures and markets a broad range of branded and non-branded generic medicines, as well as speciality injectable products. Over four decades, Hikma has grown from a regional pharmaceutical supplier to a global healthcare provider, maintaining a focus on quality manufacturing and regulatory compliance.
The company operates across three core business segments: branded generics, speciality injectables and non-branded generics.
Featured Articles
- Five stocks we like better than Hikma Pharmaceuticals
- AppLovin Stock Hits 52-Week Low as Analysts Trim Targets, Stay Bullish
- Why These 3 Equal Weight ETFs Have Outperformed the S&P This Year
- MarketBeat Week in Review – 08/03 – 08/07
- Datadog’s Drop Says More About Expectations Than Earnings
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
